Bionano Genomics (BNGO) Inventory Average (2018 - 2026)

Bionano Genomics (BNGO) has 9 years of Inventory Average data on file, last reported at $5.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 48.0% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 48.0% YoY), and the FY2025 full-year result was $8.3 million, down 51.29% from the prior year.
• Inventory Average retreated to $5.4 million in Q1 2026, from $6.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $32.8 million in Q2 2023 to a low of $5.4 million in Q1 2026.
• A 5-year average of $18.3 million and a median of $18.4 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 365.04% in 2022 and plunged 53.6% in 2025, its largest moves.
• Tracing BNGO's Inventory Average over 5 years: stood at $27.4 million in 2022, then decreased by 10.01% to $24.7 million in 2023, then plunged by 48.41% to $12.7 million in 2024, then plunged by 50.88% to $6.2 million in 2025, then slipped by 13.94% to $5.4 million in 2026.
• Business Quant data shows BNGO's Inventory Average at $5.4 million in Q1 2026, $6.2 million in Q4 2025, and $7.8 million in Q3 2025.